OLUBUNMI CORDERO: Open Payments
NPI 1508210170 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 7 payments from 5 companies in 2025. Trend: 2023 $319 · 2024 $245 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $237 |
| Corcept Therapeutics | 1 | $123 |
| AstraZeneca Pharmaceuticals LP | 1 | $116 |
| Gilead Sciences, Inc. | 2 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $99 |
Products named: Auvelity, Korlym, AIRSUPRA, Epclusa, Livdelzi.
Industry payments across TX — which companies pay providers there.
